The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 study of SEL24/MEN1703, a first-in-class dual PIM/FLT3 kinase inhibitor, in patients with IDH1/2-mutated acute myeloid leukemia: The DIAMOND-01 trial.
 
Giovanni Martinelli
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
 
Armando Santoro
Consulting or Advisory Role - ARQULE; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Incyte; MSD; Pfizer; Sanofi; SERVIER
Speakers' Bureau - Abbvie; Amgen; ArQule; AstraZeneca; Bayer; BMS; Celgene; Eisai; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Sandoz; Servier; Takeda
 
Carlo Gambacorti-Passerini
No Relationships to Disclose
 
Susana Vives Polo
Research Funding - Astellas Pharma (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Jazz Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Abbvie; Astellas Pharma; Jazz Pharmaceuticals
 
Scott R. Solomon
No Relationships to Disclose
 
Sudipto Mukherjee
Honoraria - Aplastic Anemia and MDS International Foundation; McGraw-Hill Education
Consulting or Advisory Role - Abbvie/Genentech; Blueprint Medicines; Bristol Myers Squibb; EUSA Pharma; Novartis; OncLive; Paradigm
Speakers' Bureau - EUSA Pharma
Research Funding - BMS (formerly Celgene) (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - EUSA Pharma
 
M. Yair Levy
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; Dova Pharmaceuticals; Epizyme; Gilead Sciences; GlaxoSmithKline; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; MorphoSys; Novartis; Seagen; Takeda; TG Therapeutics
 
Agnieszka Wierzbowska
Honoraria - Abbvie; Astellas Pharma; Bristol-Myers Squibb/Celgene; Janssen; Novartis; Pfizer
Consulting or Advisory Role - Abbvie; Astellas Pharma; BerGenBio; Bristol-Myers Squibb/Celgene; Janssen; Kite/Gilead; Novartis; Pfizer
Research Funding - Jazz Pharmaceuticals
 
Maria Calbacho
No Relationships to Disclose
 
Noemi Angelosanto
Employment - Ryvu Therapeutics
Stock and Other Ownership Interests - Ryvu Therapeutics
 
Antonio Galleu
Employment - Menarini
 
Simone Baldini
Employment - Menarini
 
Simona Blotta
Employment - Menarini
 
Nassir Habboubi
Employment - Stemline Therapeutics
Leadership - Stemline Therapeutics
 
Farhad Ravandi
Honoraria - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; AstraZeneca; Bristol Myers Squibb; Celgene; Jazz Pharmaceuticals; Novartis; Pfizer; Syros Pharmaceuticals; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; AstraZeneca; Bristol Myers Squibb; Celgene; Certara Inc; Jazz Pharmaceuticals; Syros Pharmaceuticals; Taiho Oncology
Research Funding - Amgen; Astex Pharmaceuticals; Biomea Fusion; Bristol-Myers Squibb; Cellerant; Macrogenics; Prelude Therapeutics; Selvita; Syros Pharmaceuticals; Taiho Oncology; Xencor
 
Pau Montesinos
Consulting or Advisory Role - Menarini; Stemline Therapeutics